Insights

Gain perspectives from experts on various policy issues and therapeutic areas through our Insights series that engages multiple managed care stakeholders in video interviews.

Interstitial Lung Disease: Immunosuppressive and Nonpharmacological Options
August 14, 2019 – 
Regarding interstitial lung disease, Alicia M. Hinze, MD, elucidates immunosuppressive approaches and beneficial lifestyle changes.
Treatment Options for Interstitial Lung Disease
August 14, 2019 – 
Shifting their focus to pharmacological management of interstitial lung disease (ILD), experts review approved treatment options.
Interstitial Lung Disease: Guidelines for Therapy
August 08, 2019 – 
Highlights from clinical guidelines and therapeutic goals related to the management of interstitial lung disease (ILD).
Economic Burden of Interstitial Lung Disease
August 08, 2019 – 
An outline of the many factors that play into the direct and indirect costs of interstitial lung disease (ILD).
Approaching Interstitial Lung Disease Management
July 31, 2019 – 
An expert identifies who manages a patient with interstitial lung disease (ILD) and what factors play into the selection of therapy.
Establishing a Diagnosis of Interstitial Lung Disease
July 31, 2019 – 
Alicia M. Hinze, MD, reflects on optimal diagnostic strategies used to identify interstitial lung disease (ILD).
Interstitial Lung Disease: Risk Factors and Comorbidities
July 24, 2019 – 
Key opinion leaders share insight on the risk factors tied to interstitial lung disease (ILD), as well as its potential comorbidities.
An Overview of Interstitial Lung Disease
July 24, 2019 – 
A comprehensive review of interstitial lung disease, its classifications, and who is involved in the management of patients.
The Future of Atopic Dermatitis Management
July 11, 2019 – 
A discussion on the future treatment landscape of atopic dermatitis in adolescents.
Recommendations for Prescribing Dupilumab
July 11, 2019 – 
Key option leaders provide community physicians with recommendations on the management of atopic dermatitis in adolescents with dupilumab.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.